| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in)/provided by financing activities | -4,552 | -3,543 |
| Net increase/(decrease) in cash, cash equivalents and restricted cash equivalents | 382 | 6,454 |
| Cash and cash equivalents at beginning of period | 4,262 | - |
| Cash and cash equivalents at end of period | 4,644 | - |
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)